- Traditional methods alone leave critical gaps — especially for complex cancer trials
- Intricate I/E criteria can bypass patients with aggressive diseases or fragmented care pathways
- Having one or more comorbidities is associated with significantly lower rates of clinical trial discussion
- Data-driven patient identification tools enable faster, more precise location of the right patients
Our People
Citeline is more than world-class data and technology … it's people.
People driven by a single purpose — to help pharma companies bring lifesaving therapies to patients faster.
Meet some of the passionate people behind our products and see why at Citeline, It's Personal.
Discover Our Stories
Make sure you advocate for your care; make sure you advocate for your loved ones' care. And have a relationship with your doctor where you can talk through the different options.
Madeline Naylor
Chief Clinical Officer
I learned the importance of listening to yourself, to your body, and trusting your intuition — no one knows you better than you do.
Claudia Maucieri
Senior Demand Generation Manager
Overall, my study experiences were positive ones, and I look forward to participating again ... in clinical research.
Darcy Grabenstein
Director, Content & Thought Leadership
I especially enjoy connecting directly with customers — hearing their challenges firsthand and then working with our internal teams to strategize solutions that make a meaningful impact.
Cassandra Tramutola
Director of Product Management,
Patient Engagement & Recruitment
Rather than waiting for patients to find a trial, we can proactively identify candidates who are genuinely likely to be eligible, before they've ever raised their hand.
Lindsay Stahl
VP and Global Head of
Patient Engagement & Recruitment
Innovation is about trying new things, stepping outside of what you’ve always done before, knowing that you might fail, and not being afraid of that.
Christina Masturzo
VP, Product
I knew I needed to be in this industry, because there’s so much valuable work we can do to smooth patients’ access to therapies and help companies bring critical therapies to market.
Ritupriya Yamujala
Senior Director, Solution Consulting and Synergy
I work with some of the smartest people in the industry, and I learn from them every day.
Will Franco
Senior Solution Consultant
Almost every study these days has such a unique patient population that recruitment needs to be tackled as if it is a rare disease study.
Claire Riches
VP, Clinical Solutions
I’m driven by the opportunity to stop disease before it spreads — using evidence to protect not just individuals, but populations.
Lavi Garg
Epidemiologist I, India
Working as an epidemiologist at Norstella, I realized that while I wasn’t treating patients directly, I was preventing disease — protecting thousands, even millions. What I once hoped to do for individuals, I was now able to do at scale, which drives my passion for this field.
Souvik Mohanta
Epidemiologist I, India
I strive to be — a professional who learns, contributes, and creates a better world for the next generation.
Jana Moonmoon
Domain Manager
Closing the Patient Recruitment Gap
From Strategy to Patient Access
Purpose and expertise only matter if they lead to real-world impact.
Citeline PatientMatch: A deeper look
Real-world data, AI, and human expertise identify the right patients earlier.
Download PDF ➜Citeline PatientMatch in practice
Taking an SCLC Phase II trial from poor referrals to first randomization in one week.
DOWNLOAD CASE STUDY ➜See Citeline PatientMatch in action
Book a call with a Patient Engagement & Recruitment expert today.